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A  number of recent papers  have  described  the production of antisera and 
monoclonal antibodies against cloned antigen-specific, major histocompatibility 
complex-restricted (Ag/MHC-specific)  ~ or ailo-reactive T  cells.  In each case the 
antibodies were assayed for activity against Ag/MHC receptors on these T  cells 
by their ability to substitute for Ag/MHC, or inhibit Ag/MHC reaction (1-8). 
Interestingly, in every case so far in which antibodies with these activities have 
been described, they have proved to be clone-specific in their activity, suggesting 
that they recognize the idiotypic portion  of the Ag/MHC receptors on target 
cells. This, of course, has been an important point in proving that the antibodies 
in question were indeed directed at the Ag/MHC receptor on the T  cell, and 
not  some  other,  perhaps  associated,  molecule such  as  lymphocyte functional 
antigen-l, T3, L3T4, Lyt-2, or T8 (9-13). 
In several cases the target molecules of these antibodies have been identified 
by  immunoprecipitation (4-7,  14).  They are  80-90-kdalton  disulfide-bonded 
dimers of two dissimilar glycopeptide chains of molecular weights varying from 
47 kdaltons to 39 kdaitons, depending on the T  cell and species from which they 
were derived. Both chains vary in amino acid sequence between clones (7). 
The experiments presented in  this paper  were designed to bolster the idea 
that the T  cell clone-specific antibodies described so far do indeed bind to the 
Ag/MHC receptor on T  cells.  A clone-specific monoclonal antibody, KJ1-26.1, 
isolated on  the  basis  of its  reactivity with a  chicken ovalbumin (cOVA)/I-A  d- 
reactive T  cell hybridoma, D0-1 1.10, was tested for its ability to react with 397 
independent T cell hybridomas derived from BALB/c T cells primed with cOVA. 
Of these  397  T  cell  hybridomas only one,  7D0-286,  bound  the  monoclonal 
antibody KJ1-26.1  specifically. 7D0-286  proved to share the unusual Ag/I fine 
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specificity  of  D0-11.10  both  for  Ag  and  I.  Thus,  reactivity  with  KJ1-26.1 
predicted the fine specificity of T  cell hybridoma both for Ag and I. This result 
strongly  suggests  that  the  monoclonal  antibody,  KJI-26.1,  binds  an  idiotypic 
determinant on the Ag/MHC receptors of D0-11.10 and 7D0-286. 
Materials and Methods 
Animals.  BALB/c  By  (BALB/c),  C57BL/10  (B10),  B10.BR,  B10.M,  B10.Q, 
B10.S(7R), and CBA/J animals were either bred in our colony from breeding triplets 
purchased from The Jackson  Laboratory, Bar  Harbor, ME, or were the gifts of Drs. 
Chella  David  (The  Mayo  Clinic,  Rochester,  MN)  and  Donald  Shreffler (Washington 
University, St Louis, MO). 
Antigens and Other Reagents.  Chicken (c) and turkey (t) ovalbumin were purchases from 
Sigma Chemical Co. St. Louis, MO. 
Jungle fowl Of), duck (d), pigeon (p), and widgeon (w) OVA were prepared by standard 
methods (15)  from eggs provided by the  inmates of the  Denver Zoo courtesy of Ed 
Schmitt, the curator. Bobwhite quail (q) OVA was prepared by similar methods from eggs 
obtained from  the  GQF  Manufacturing  Co.  Savannah,  GA.  Reagents  for ELISA, p- 
nitrophenyl phosphate, and alkaline phosphatase-coupled rabbit anti-mouse immunoglob- 
ulin, were obtained from the Sigma Chemical Co. 
T Cell Hybridomas.  T  cell hybridomas were produced as previously described by the 
fusion of Ag/MHC-reactive T  cell blasts to the AKR T  cell thymoma, BW5147 (15, 16). 
The T cell hybridomas DO- 11.10 and 7D0-286.2, for example, were produced by priming 
BALB/c mice in the base of the tail with cOVA.  7 d  later, cells from draining lymph 
nodes were harvested and cultured for 4  d  with Ag followed by 3 d  incubation with 
interleukin  2  (IL-2).  Live  cells  were  isolated  and  hybridomas prepared  by  standard 
techniques. DO-11.10  was picked and cloned on the basis of its reactivity with cOVA/H- 
2  d (3).7D0-286.2 was picked and cloned on the basis of its reactivity with a monoclonal 
anti-Ag/MHC receptor antibody prepared against DO-11.10 (see below). DO-11,10 was a 
fusion  product of female BALB/c  mice,  7D0-286.2  was  derived from  male  BALB/c 
donors. 
Monoclonal Antibodies.  Monocional antibodies against  Ag]MHC receptors on T  cell 
hybridomas were prepared as previously described (5). Two were used in the experiments 
described in this paper. KJ1-26.1, raised against and specific for the Ag/MHC receptor 
on D0-11.10 (5), and KJ12-98.15, raised against and specific for the receptor on 3DT- 
52.5  (7),  a  T  cell hybridoma which  recognizes D  d (17).  The anti-Thy-1  monoclonal 
antibody T24/40.8  (18)  was  used  as  a  control in  ELISA.  The  following monocional 
antibodies were used to map I-region specificities of T  cell hybridomas, MK-D6, specific 
bd  dk  for I-A  d'p'q (16), M5/114, specific for I-A • , I-E '  (19), 8KP, specific for I-A  b'k (amongst 
many) but not I-A  n (20), 14-4-4,  specific for I-E  d'k (21), MK-S4 specific for I-A  S  (16), and 
11-5.2 specific for I-A  k (22). 
Assay for Ag]MHC Recognition.  Receptors for Ag/MHC on T  cell hybridomas were 
assayed by standard methods (16). Briefly, T  cell hybridomas were incubated in micro- 
culture wells for 24 h with Ag (usually at  1 mg/ml) and Ag-presenting cells. These last 
were B cell lymphomas or hybridomas at 10h/well or 4,000 rad-irradiated spleen cells at 
106/well. After incubation the supernatants (SN) of these cultures were assayed for IL-2, 
produced by the T  cell hybridomas in response to Ag/MHC.  IL-2 concentrations were 
estimated by serially diluting the SN and measuring their ability to support the growth 
and survival of the  IL-2-dependent T  cell line HT-2 (the kind gift of Dr. J. Watson, 
Auckland, New Zealand). The first dilution in a serial titration that yielded <90% viable 
HT-2 cells 24 h later was said  to contain  1 U  of IL-2.  10 U/ml IL-2 was the minimum 
detectable by this assay. 
Karyotyping.  T  hybridoma cells were prepared for karyotyping by standard methods. 
They were incubated with 0.2 tzg/ml colchicine for 30 min at 37°C. After pelleting, they 
were incubated in  0.075  M  potassium chloride for  10  min at  37°C,  spun  down,  and 
resuspended in fixative (3 parts methanol/1 part glacial acetic acid). After 20 min fixation MARRACK ET  AL.  1637 
at room temperature the cells were thoroughly washed in fixative before being dropped 
from a height onto ethanol-washed,  water-covered slides. Banding was done after heating 
the slides at 95°C for 10 rain by incubating the slides for 10-90 s in tryspin (23), followed 
by washing  and  Giemsa  staining.  Chromosome markers were assigned  by the rules  of 
Nesbitt and Francke (24). 
ELISA.  T  hybridoma cells were assayed for the presence of cell surface antigens  by 
ELISA.  The  procedures  used  have  already  been  described  (25). Briefly  3  ×  10  ~ T 
hybridoma  cells  were incubated  in  100  #1  of the  neat  culture  SN  of an  anti-Thy-1 
secreting hybridoma  (18),  or a  1:250  dilution  of ascites  produced by the anti-T  cell 
idiotype-secreting  B cell hybridomas KJ1-26.1 or KJ12-98.15.  The cells were then thor- 
oughly washed  before incubation with  1:500 alkaline  phosphatase coupled rabbit anti- 
mouse immunoglobulin  (Sigma Chemical  Co.).  After thorough  washing  the cells were 
incubated at 37°C with p-nitro phenyl phosphate in pH 10.4 buffer (26). Optical densities 
(OD)  were then  read  using  an  ELISA reader (Bio-Tek  Instruments,  Inc.,  Burlington, 
VT). 
Immunoprecipitation.  Surface membrane proteins on T  cell hybridomas were labelled 
with  12~I using  Iodo-gen  (Pierce  Chemical  Go.,  Rockford,  IL) (5). Cell  lysates  were 
prepared with NP-40 (5) and immunoprecipitated with monoclonal  antibody coupled to 
Sepharose beads (Pharmacia,  Uppsala,  Sweden)  (27). Immunoprecipitates were washed 
thoroughly before solubilization  by boiling in electrophoresis loading  buffer (28). Some 
samples were also reduced by treatment with 5% 2-mercaptoethanol during the boiling. 
Reduced and  unreduced  samples  were  electrophoresed  on  10%  polyacrylamide  gels 
(PAGE) containing SDS (28). 
Results 
Production of  a T Cell Hybridoma That Cross-reacts Idiotypically with DO-11.10.  We 
have recently reported (5) the properties of a  monoclonal antibody, KJ1-26.1, 
which appears to bind all or part of the receptor for cOVA/I-A  d on the T  cell 
hybridoma  D0-11.10.  In  our original  studies this antibody was shown  to bind 
D0-11.10 and cOVA/I-Ad-responsive subclones of this hybridoma, but the anti- 
body did not bind any other T  cell hybridoma screened, nor to subclones of DO- 
11.10 that  had  lost the ability to  respond  to cOVA/I-A  d.  We were curious to 
find out,  however,  how frequent  the  idiotype recognized  by KJ1-26.1  was on 
BALB/c T  cells, so for this and other reasons we decided to screen a number of 
independent  T  cell  hybridomas  for  reactivity  with  KJ1-26.1  or  KJ12-98,  a 
monoclonal antibody specific for the receptor for D d on the T  cell hybridoma 
3DT-52.5 (7).  Since D0-11.10  was derived from BALB/c T  cell blasts specific 
for cOVA we reasoned that we would be most likely to find a KJ1-26.1  idiotype- 
bearing cell amongst  this  population.  Hybridomas prepared  from these T  cell 
blasts were therefore screened.  In the vast majority of cases the screening used 
ELISA to detect KJ1-26.1-binding  T  cell hybridomas.  307 independent  T  cell 
hybridomas prepared  in  four different  fusions were thus  tested;  some sample 
results  are  shown  in  Table  I.  All  the  uncloned  T  cell  hybridomas  we  tested 
reacted well with the anti-Thy-1  antibody. 
A few hybridomas reacted to a small degree with either KJ1-26.1 or KJ12-08. 
For example of the hybrids shown in Table I, 7D0-248 had this property. This 
hybrid, and others like it, were reassayed and showed no binding to either KJ 1- 
26.1  or KJ12-O8 in subsequent assays. The small positive reading on first assay 
was probably due  to contamination  of the  hybridoma  cells with  dead  cells or 
spleen cells from the initial fusion well when they were used in the first assay. A 
few  hybridomas  gave  very  large  ELISA  readings  regardless  of the  primary 1638  AN  ANTI-T  CELL  IDIOTYPE  DEFINES  ANTIGEN  AND  1  SPECIFICITY 
TABLE  I 
Sample Screening of T Hybridomas  for Reactivity with KJ I-26.1 
T  cell hybridoma 
ELISA OD x  1,000 after incubation with 
KJ1-26.1  KJ12-98  T24/40.8 
7D0-185  777  874  966 
7D0-248  63  33  287 
7D0-250  17  6  202 
7D0-251  14  2  157 
7D0-272  21  23  122 
7D0-277  -7  -10  89 
7D0-282  10  2  298 
7D0-286  355  103  314 
7D0-290  1  10  283 
D0-11.10  212  3  291 
antibody added to the assay wells.  In  Table  I,  7D0-185  is an  example of this. 
This  hybridoma, and others like it,  continued  to give high  ELISA readings  in 
subsequent assays, i.e.,  they appeared to bind nonspecifically to either,  or both 
of, the primary or secondary antibody reagents used in the ELISA. Hybrids of 
this  type  showed  no  particularly  unusual  reactivity  with  OVA/H-2  d  in  IL-2 
production assays and these reactions were not inhibited or stimulated by KJ1- 
26.1  or KJ12-98.15. These hybrids were therefore not studied further. 
One hybridoma, 7D0-286, reacted as strongly with KJ 1-26.1 as with anti-Thy- 
1  (Table  I).  This  reaction  was  consistent  in  three  independent  assays.  The 
hybridoma also reacted, less strongly, with KJ12-98.15. The reaction with KJ12- 
98.15 was variable and disappeared after prolonged culture and cloning of the 
line, moreover it did not appear to be specific since KJ 12-98.15 did not precipi- 
tate anything from 7D0-286 (see Fig. 2), nor did it interfere with or mimic any 
reaction of the cell (data not shown). 
Because 7D0-286 reacted strongly and consistently with KJ 1-26.1 it was chosen 
for further examination. 
7D0-286 Has a Rare Specificity  for Ag/MHC, Shared with DO-11. I0.  Preliminary 
assays showed that  7D0-286 responded well to cOVA/I-A  d by producing  IL-2, 
and  that  this  response,  like that  of D0-11.10,  could be inhibited  by KJ1-26.1. 
7D0-286  was therefore  cloned at  limiting  dilution,  all  seven clones tested  re- 
sponded to cOVA/I-A  d, in every case this response was inhibited by KJ1-26.1. 
Clone 7D0-286.2 was chosen for further study. 
The  T  cell  hybridoma,  D0-11.10,  has  a  rare  fine  specificity for  cOVA,  as 
measured by its ability to respond to a  variety of bird OVA in the presence of 
H-2d-bearing antigen-presenting  cells, and by its ability to respond to six inde- 
pendent  H-2  hapiotypes  in  the  presence  or  absence  of cOVA.  In  previous 
experiments  (not  shown  here)  we have  compared  the  fine  specificities of D0- 
11.10 and  207  other independent  T  cell hybridomas,  randomly  selected from 
four different  fusions of cOVA-specific BALB/c T  cell blasts to BW5147,  by 
these criteria.  None of the  randomly  selected hybridomas had  the same cross- 
reactivity pattern  as D0-11.10.  We reasoned  that  if KJ1-26.1  were specific for 
an idiotypic determinant on the Ag/MHC receptor of D0-11.10. then 7D0-286.2 MARRACK  ET  AL.  1639 
should show the same fine specificity for Ag/MHC as D0-11.10.  The two T  cell 
hybridomas, and two control cOVA/I-Ad-specific BALB/c-derived T  cell hybri- 
domas, 3D0-18.3  and 3D0-54.8  (15) were therefore tested for IL-2 production 
in the presence of various stimuli. Our results are shown in Tables II-V. 
Table II represents the consequences of challenging the four T cell hybridomas 
with OVA from different birds in the presence of A20-1.11,  the H-2d-bearing, 
Ag-presenting B cell lymphoma (29,  30).  D0-11.10  and  7D0-286.2  responded 
well to c and jfOVA and weakly, in  this experiment, to tOVA.  They did  not 
respond to any other bird OVA tested. The two control T cell hybridomas, 3D0- 
18.3 and 3D0-54.8,  had different reactivity patterns.  3D0-18.3  responded well 
to c and jfOVA, and also to ph and qOVA; 3D0-54.8  responded strongly to c, 
if,  and qOVA.  Thus,  D0-11.10  and  7D0-286.2  share fine specificity for bird 
OVA and their cross-reactivity pattern is not common to many BALB/c anti- 
cOVA T  cells. 
TABLE  II 
DO-11.10 and 7D0-286.1 Share Fine Specificities  for Bird OVA 
Ag in culture* 
U/ml IL-2 secreted by 
D0-11.10  7D0-286.2  3D0-18.3  3D0.54.8 
cOVA  5,120  2,560  10,240  1,280 
if  OVA  640  640  5,120  320 
phOVA  <10  <10  10,240  <10 
tOVA  40  20  <10  40 
qOVA  <10  <10  5,120  640 
wOVA  <10  <10  <10  <10 
gOVA  <10  <10  <10  <10 
dOVA  <10  <10  <10  <I0 
* All cultures contained 105 A20-1.11 H-2  d Ag-presenting  cells. 
TABLE  III 
DO-11.10 and 7D0-286.2 Share H-2 Reactivities 
Culture conditions 
Ag-presenting  cells  cOVA  DO- 11.10 
U/rnl IL-2 secreted by 
7D0-286.2  3D0-18.3  3D0-54.8 
B10  -  20  l0  <10  <10 
+  1,280  1,280  <10  <10 
B10.D2  -  <10  <10  <10  <10 
+  2,560  1,280  10,240  1,280 
BI0.M  -  <10  <I0  <10  160 
+  <I0  <10  <10  160 
B10.BR  -  <10  <10  <10  20 
+  <10  <10  <10  20 
B10.Q  -  <10  <10  <10  <10 
+  <10  <10  <10  <10 
B10.S(7R)  -  <10  <10  <10  80 
+  <10  <10  <10  80 
CBA/J  -  <10  <10  ND  ND 
+  <10  <10  ND  ND 
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TABLE  IV 
The Restriction  Specificities of DO-11.10 and 7D0-286.2 Map to LA  d or LA  b 
U/ml IL-2 secreted by: 
Antibody in culture  DO- 11.10  7D0-286.2 
+B10*  +B10.D2*  +B10*  +B10.D2* 
MK-D6  640  <10  1,280  <10 
M5/114  <10  <10  <10  <10 
8KP  <10  1,280  <10  320 
14-4-4  640  1,280  640  320 
MK-S4  640  1,280  640  320 
11-5.2  640  1,280  640  320 
KJ1-26.1  20  10  10  10 
--  2,560  2,560  2,560  640 
* All cultures contained cOVA and B10 or B10.D2 spleen cells as Ag-presenting cells. 
TABLE  V 
D0-11.10 and 7D0-286.2 Respond to the Same cOVA Peptide 
Ag in  Units IL-2 secreted by 
culture*  D0-11.10  7D0-286.2  3D0-18.3  3D0-54.8 
cOVA  <10  ND  ND  ND 
p143  1,280  320  <10  640 
* Cultures contained 105 glutaraldehyde-fixed A20-1.11  cells plus  1 mg/ 
ml G75 Sephadex purified cOVA or 400 ng/ml p  143. 
Table  III demonstrates  that  D0-11.10 and  7D0-286.2  responded to cOVA/ 
H-2  d but not to H-2  r, H-2  q, H-2  t2 or Mls  a, with or without OVA. Both hybridomas 
responded  weakly to  H-2  b.  These  responses  were  markedly  increased  by the 
addition of cOVA. Neither of the two control T  cell hybridomas shown, not any 
of 205  other T  cell hybridomas (not shown) had  the same reaction  pattern  in 
this assay as DO-11.10 and 7D0-286.2 
To  do the  experiments  shown  in  Table  IV  we  tested  the  responses of D0- 
11.10 or 7D0-286.2 to cOVA/H-2  b and cOVA/H-2  a in the presence of various 
monoclonal  antibodies.  These  antibodies  were  all  present  at  concentrations 
known  to  inhibit  effectively reactions  for  which  their  specificities  would  be 
appropriate.  Monocional antibody culture  SN were present at a  1:10 dilution, 
ascites at  1:100 or  1:250. The responses of D0-11.10 and 7D0-286.2  to OVA/ 
H-2  b were inhibited by the anti-I-A b monoclonal  antibodies M5/114  and  8KP, 
and  also by the  anti-D0-11.10  Ag/MHC receptor antibody  KJ1-26.1.  The  re- 
sponses of the same T  cell hybridomas to cOVA/H-2  d were blocked by the anti- 
I-A  d monoclonal antibodies MK-D6 and  M5/114, as well as by KJ1-26.1.  Thus 
both T  cell hybridomas are specific for cOVA/I-A  d or cOVA/I-A  b. 
We  have  recently  shown  that  D0-11.10  and  3D0-54.8  recognize  a  tryptic 
peptide (amino acids 316-342) of cOVA, when presented by I-Ad-bearing cells, 
even if these Ag-presenting cells have been fixed with glutaraldehyde (reference 
15,  and  unpublished  observations).  The  fixed cells  were,  however,  unable  to 
present  intact  cOVA  to  these  hybridomas  presumably because  they could  no 
longer  "process"  the  intact  protein.  The  tryptic  peptide  has  recently  been MARRACK ET  AL.  1641 
synthesized  for  us  (with  the  addition  of a  C  terminal  tyrosine)  by  Dr.  Gary 
Matsueda,  Massachusetts General Hospital, Boston, MA. The synthetic peptide 
is called p143. D0-11.10 and 3D0-54.8 respond well to p143, presented on live 
or fixed I-Ad-bearing cells. 7D0-286.2 was therefore tested for the same activity. 
As shown in Table  V  fixed A20-1.11  cells presented p143  to D0-11.10,  3D0- 
54.8,  and  7D0-286.2,  but  not  to  3D0-18.3,  which  is  known  to  recognize  a 
different  peptide  derivative  of cOVA  (15).  Thus,  D0-11.10  and  7D0-286.2 
recognize the same peptide fragment of cOVA. 
7D0-286.2 Is Not a Reisolate of DO-ll. 10.  The experiments described above 
show that the Ag and H-2 specificities of 7 D0-286.2 and DO- 11.10 are both rare, 
and  indistinguishable.  Since  D0-11.10  is almost always being cultured  by one 
member or another of our laboratory it was possible that 7D0-286.2 was not an 
independent T  cell hybridoma, but simply DO- 11.10 that had accidently contam- 
inated the 7D0 fusion plates. One cell would have been sufficient to give us the 
results  we have  reported  so far.  Even  though  every precaution  was taken  to 
ensure that  this would not occur, and even though contamination  of this type 
has not previously been observed in our laboratories, we felt we should demon- 
strate directly that this had not happened. 
It is our experience that T  cell hybridomas, even though they are products of 
the fusion of a  normal  mouse T  cell (containing  40 chromosomes) to the same 
tumor cell parent,  BW5147, contain variable numbers of normal and abnormal 
mouse chromosomes (31). Most of the abnormal chromosomes seem to be derived 
from BW5147, which contains a  number of characteristic  chromosomes of this 
type (32).  Others  appear  to  form  soon after  the  fusion  of the  normal  T  cell 
parent and BW5147, by fusion or rearrangement of chromosomes in the hybrid. 
The creation of the abnormal chromosomes seems to be an early rather than a 
late event in the life history of hybridomas, since once the hybridoma has been 
cloned marker  chromosomes remain  constant.  Subcloning the hybridoma may 
lead to the production of subclones that have lost particular abnormal chromo- 
somes, but no new ones appear (unpublished observations). 
D0-11.10  was  derived  from  a  female  BALB/c  mouse;  BW5147  does  not 
contain a Y chromosome; the normal T  cell parent of 7D0-286.2, on the other 
hand,  was male.  We therefore  karyotyped  D0-11.10  and  7D0-286.2  with  the 
hope that the presence or absence of a  Y chromosome, as well as clone-specific 
distribution of chromosomes would allow us to distinguish unequivocally the two 
hybridomas. Sample spreads are shown in Fig.  1. 
Even  in  these  cloned  T  cell  hybridomas,  chromosome  numbers  did  vary 
somewhat from  spread  to spread.  Nevertheless,  D0-11.10  and  7D0-286.2  did 
differ  chracteristically.  For  example  all  spreads  of 7D0-286.2  contained  a  Y 
chromosome  (in  Fig.  1 an  arrow  points  to  this  chromosome);  this  was  never 
observed in a  karyotype of D0-11.10.  7D0-286.2  cells consistently contained  2 
chromosomes 4, 2 or 3 chromosomes 12, and one or zero chromosomes 18. D0- 
11.10 spreads always contained one normal chromosome 4, 4  normal chromo- 
somes 12, and  2 or 3 chromosomes  18. These data demonstrate  unequivocally 
that 7D0.286.2 is not a reisolate of D0-11.10. 
Immunoprecipitation  of 7D0-286.2.  D0-11.10 and  7D0-286.2  were surface la- 
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FICURE  1.  Chromosomes of D0-11.10 and 7D0-286.2.  D0-11.10  and 7D0-286.2 were pre- 
pared for karyotyping as described in  Materials and  Methods.  An arrow points to  the  Y 
chromosome in 7D0-286.2. 
FIGURE 2.  lmmunoprecipitation of D0-11.10  or 7D0-286.2  by KJ1-26.1  and KJ12-98.15. 
Cell lysates from J  25I-surface-labeled T cell hybridomas were incubated with KJ 1-26.1 or KJ 12- 
98.12 coupled to sepharose beads. Samples were analyzed by SDS-PAGE on 10% gels with or 
without reduction by 2-mercaptoethanol. 
or  KJ12-98.15.  Samples  were  run  nonreduced  or  reduced  on  SDS-PAGE.  As 
shown in Fig. 2 and previously (5), KJ1-26.1  precipitated an 85-kdalton molecule 
from  D0-11.10  that after reduction ran as a  diffuse band of ~43  kdaltons. KJ1- 
26.1  precipitated a  similar molecule from  7D0-286.2.  KJ12-98.15  did not pre- 
cipitate any detectable material from 7D0-286.2.  Therefore,  the gross biological MARRACK  ET  AL.  1643 
properties of the Ag/MHC receptor on D0-11.10 and 7D0-286.2  appear to be 
similar. 
Discussion 
In this paper we show that a T  cell hybridoma, 7D0-286.2, selected because it 
binds an antibody, KJ1-26.1,  which is thought to bind to all or part of the Ag/ 
MHC receptor on a different T cell hybridoma, D0-11.10, has the same specificity 
both for Ag and H-2 as DO-11.10.  Both T  cell hybridomas respond strongly to 
cOVA/I-A  d, jfOVA/I-A  d, and cOVA/I-A  b, and weakly to tOVA/I-A  d and I-A  b 
alone. 
These fine specificities are relatively rare amongst T  cell  hybrids prepared 
from BALB/c T  cell blasts specific for cOVA, in  fact others with this pattern 
have not been seen amongst 207  tested.  In addition none other of 397  inde- 
pendent  T  cell  hybridomas  tested  reacted  specifically with  the  anti-receptor 
antibody KJ1-26.1. 
From these results we would like to draw several conclusions. First, and most 
importantly, we feel that these results show unequivocally that KJ1-26.1  binds 
to all or part of the receptor for cOVA/I-A  d on D0-11.10 and 7D0-286.2,  since 
the presence of the idiotype predicted exactly the specificity of the T  cells.  Prior 
to this discovery the evidence that antibodies of this type reacted with Ag/MHC 
receptors on  T  ceils rested on the facts that they are clone-specific, that they 
block responses against and binding to Ag/MHC and that they do not bind to 
subclones of T  cell hybridomas thought to have lost the ability to put Ag/MHC 
receptors on their surfaces (1-8,  14).  Of course, in the case of the long-sought- 
for  T  cell  Ag/MHC  receptors,  the  more  evidence  that  can  be  mustered  to 
support the candidacy of a particular molecule the better; a demonstration that 
the suspect binds to Ag/MHC, for example, would be most welcome. Unfortu- 
nately, our preliminary attempts  to  demonstrate this  have been  unsuccessful, 
perhaps because of obligatory requirements for other molecules, LFA-1, L3T4, 
or Lyt-2 (9-13). In lieu of such data we feel that our demonstration that idiotype 
determines specificity is a useful addition to the literature on this subject. 
The  fact that  reaction with  KJ1-26.1  predicted the fine specificity of 7D0- 
286.2  both for Ag and MHC places certain restrictions on models for how Ag/ 
MHC recognition occurs. Certainly, it is compatible with a single receptor model 
(33), as is the fact that KJ1-26.1, and other antibodies like it, have been shown 
to precipitate 80-90-kdalton disulphide-bonded heterodimers from cell surfaces 
which, on reduction yield two polypeptide chains, both of variable sequence of 
mol wt 39-47 kdaltons (4-7,  14).  Moreover, recently a number of other publi- 
cations  have  also  suggested  that  a  single  receptor  model  may  describe  the 
structure of the T  cell receptor and its ligands (16, 34, 35). To allow the data in 
this paper to be compatible with two receptor models (36), we have to postulate 
that the structure of the Ag and MHC receptors are not independent: one might 
be derived from the other (37),  or they might be constructed from different 
parts of the same polypeptide chains (38). Constraints of this type have, of course, 
already been  imposed  on  two  receptor theories by  the existence of antigen- 
specific, MHC-iinked Ir genes. 
A second point worth noting is that the idiotype recognized by KJ 1-26.1  occurs 1644  AN  ANTI-T  CELL IDIOTYPE DEFINES ANTIGEN AND  I SPECIFICITY 
relatively  infrequently.  Only  1 of about  400  T  cell  hybridomas  was found to 
bear  it,  even  when  the  hybridomas  were derived from  T  cells with  the  same 
gross  Ag/MHC  specificity  as  the  original  target  of KJ1-26.1.  Although  it  is 
impossible to generalize  from this  single example,  the result is consistent with 
the idea that  the variability of T  cell Ag/MHC receptors is relatively large,  at 
least as large as that of B cells. 
Summary 
In  order  to  prove  that  a  monoclonal  antibody,  KJ1-26.1,  reacted  with  the 
idiotypic portion of the receptor for antigen plus major histocompatibility com- 
plex product (Ag/MHC) on the T  cell hybridoma D0-11.10,397 independent T 
cell hybridomas  prepared  from  BALB/c T  cells primed  with  ovalbumin  were 
screened by ELISA for reactivity with the antibody. Of these T  cell hybridomas 
one,  7D0-286, and a  subclone of this hybridoma,  7D0-286.2,  reacted strongly 
and consistently with KJ 1-26.1. Further analysis revealed that KJ 1-26.1 blocked 
the reaction  of 7D0-286  with  Ag/MHC, and  that  7D0-286  had  the same fine 
specificity both for Ag and  MHC as D0-11.10.  None of 207  other BALB/c T 
cell hybridomas specific for ovalbumin shared these fine specificity patterns. 
Thus,  reaction  with  KJ1-26.1  defined the  specificity of a  T  cell  hybridoma 
both for Ag and MHC, suggesting that KJ1-26.1  reacted with the receptors for 
Ag/MHC on the T  cells in question. 
KJ1-26.1 precipitated an 85-kdalton molecule from 7D0-286.2 that on reduc- 
tion ran as a diffuse spot of ~43  kdaitons.  A similar molecule was precipitated 
from D0-11.10. 
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